Pfizer company outlook: a "Covid-19 dependent" business?
Autor(a) principal: | |
---|---|
Data de Publicação: | 2022 |
Tipo de documento: | Dissertação |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/10362/148071 |
Resumo: | This equity report aims at analyzing and evaluating the pharmaceutical company Pfizer in a context of the global pandemic and the possible outcomes of the post-pandemic. We also researched the latest industry trends and analyzed the pharma regulation, M&A activity, patents, and emerging technologies. Thorough the report, we explained the methodologies and how recent industry and economic factors will affect the revenues of the main Pfizer’s pharmaceutical products |
id |
RCAP_8b50fce41e02ee4e3f3987ae9379205d |
---|---|
oai_identifier_str |
oai:run.unl.pt:10362/148071 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Pfizer company outlook: a "Covid-19 dependent" business?ValuationInnovationR&DHealthcareCovidVaccinesPatentsOncologyDomínio/Área Científica::Ciências Sociais::Economia e GestãoThis equity report aims at analyzing and evaluating the pharmaceutical company Pfizer in a context of the global pandemic and the possible outcomes of the post-pandemic. We also researched the latest industry trends and analyzed the pharma regulation, M&A activity, patents, and emerging technologies. Thorough the report, we explained the methodologies and how recent industry and economic factors will affect the revenues of the main Pfizer’s pharmaceutical productsAntunes, FranciscoRUNArias, David2023-01-24T17:03:30Z2022-06-072022-05-192022-06-07T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfhttp://hdl.handle.net/10362/148071TID:203136055enginfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-03-11T05:29:26Zoai:run.unl.pt:10362/148071Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T03:53:11.574325Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Pfizer company outlook: a "Covid-19 dependent" business? |
title |
Pfizer company outlook: a "Covid-19 dependent" business? |
spellingShingle |
Pfizer company outlook: a "Covid-19 dependent" business? Arias, David Valuation Innovation R&D Healthcare Covid Vaccines Patents Oncology Domínio/Área Científica::Ciências Sociais::Economia e Gestão |
title_short |
Pfizer company outlook: a "Covid-19 dependent" business? |
title_full |
Pfizer company outlook: a "Covid-19 dependent" business? |
title_fullStr |
Pfizer company outlook: a "Covid-19 dependent" business? |
title_full_unstemmed |
Pfizer company outlook: a "Covid-19 dependent" business? |
title_sort |
Pfizer company outlook: a "Covid-19 dependent" business? |
author |
Arias, David |
author_facet |
Arias, David |
author_role |
author |
dc.contributor.none.fl_str_mv |
Antunes, Francisco RUN |
dc.contributor.author.fl_str_mv |
Arias, David |
dc.subject.por.fl_str_mv |
Valuation Innovation R&D Healthcare Covid Vaccines Patents Oncology Domínio/Área Científica::Ciências Sociais::Economia e Gestão |
topic |
Valuation Innovation R&D Healthcare Covid Vaccines Patents Oncology Domínio/Área Científica::Ciências Sociais::Economia e Gestão |
description |
This equity report aims at analyzing and evaluating the pharmaceutical company Pfizer in a context of the global pandemic and the possible outcomes of the post-pandemic. We also researched the latest industry trends and analyzed the pharma regulation, M&A activity, patents, and emerging technologies. Thorough the report, we explained the methodologies and how recent industry and economic factors will affect the revenues of the main Pfizer’s pharmaceutical products |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022-06-07 2022-05-19 2022-06-07T00:00:00Z 2023-01-24T17:03:30Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/masterThesis |
format |
masterThesis |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10362/148071 TID:203136055 |
url |
http://hdl.handle.net/10362/148071 |
identifier_str_mv |
TID:203136055 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799138123047763968 |